In-Vivo Imaging Market Growth, Size, Trends, Regional Overview and Leading Company Analysis
Data Bridge Market Research analyses that the In-vivo imaging market which was USD 896.716 million in 2022, is expected to reach USD 1459.71 million by 2030, at a CAGR of 6.28% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market research analysis data included in this report lend a hand to businesses for planning of strategies related to investment, revenue generation, production, product launches, costing, inventory, purchasing and marketing. What's more In-vivo imaging market, report presents the data and information for actionable, most recent and real-time market insights which makes it easier to even take critical business decisions.
Download Copy of this Report to understand structure of the complete @ Market Definition:
In vivo imaging is the visualization of various life processes within an organism. With one-touch, user-defined or pre-set PC controls for repeatable and precise imaging, an in vivo imaging system aids in mechanizing in vivo imaging research. Depending on the application, in vivo imaging systems can be used on both animals and humans. In research laboratories, in vivo imaging systems are typically used to study the activity of a drug on animals such as albino mice, albino rats, and so on. These small animal imaging procedures include a full body scan as well as a targeted scan. Full body scan is a popular imaging method because it is inexpensive and can thus be used for commercialization and regular validation of new drugs.
Market Overview:
Rapid technological advancement in molecular imaging is one of the key factors expected to accelerate the growth and demand for In-vivo imaging. Furthermore, an increase in public-private initiatives and high funding to support preclinical research are expected to contribute to the global market's growth from 2023 to 2030. The rapid rise in demand for noninvasive small-animal imaging techniques and rapid advancements in healthcare services and technology are also expected to boost market growth. Furthermore, an increase in awareness of the benefits of early disease detection and an increase in the rate of clinical acceptance of multi-modality imaging systems are important factors.
Market Scope and Size:
The In-vivo imaging market is segmented on the basis of modality, reagents, techniques and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Modality
• Optical Imaging Systems
• Bioluminescence/fluorescence imaging systems
• Standalone fluorescence imaging systems
• Optical + X-ray/optical + CT
• Nuclear Imaging Systems
• Micro-PET systems
• Micro-SPECT systems
• Trimodality (SPECT/PET/CT) systems
• Micro-MRI
• Micro-Ultrasound
• Micro-CT
• Photoacoustic Imaging Systems
• Magnetic Particle Imaging Systems
Reagents
• Optical Imaging Reagents
• Bioluminescent imaging reagents
• Fluorescent imaging reagents
• Nuclear Imaging Reagents
• PET tracers and SPECT probes
• MRI Contrast Agents
• Gadolinium-based
• Iron-based
• Manganese-based
• Ultrasound Contrast Agents
• CT Contrast Agents
• Iodine-based
• Barium-based
• Gold nanoparticles
Country Level Analysis:
The countries covered in the In-vivo imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Key Players:
Some of the major players operating in the In-vivo imaging market are:
• PerkinElmer Inc. (U.S.)
• Bruker (U.S.)
• FUJIFILM Holdings America Corporation (Canada)
• Siemens (Germany)
• Miltenyi Biotec (Germany)
• CMR Naviscan (U.S.)
• SCANCO Medical AG (Switzerland)
• Aspect Imaging Ltd. (Israel)
• Mediso Ltd. (U.S.)
• LI-COR, Inc. (U.S.)
• Takara Bio Inc. (Japan)
• MILabs B.V. (Netherlands)
• MR Solutions (U.K.)
• Trifoil Imaging (U.S.)
Download Sample PDF Copy of this Report to understand structure of the complete report @ https://www.databridgemark...
TABLE OF CONTENTS:
Part 01: Executive
Data Bridge Market Research analyses that the In-vivo imaging market which was USD 896.716 million in 2022, is expected to reach USD 1459.71 million by 2030, at a CAGR of 6.28% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market research analysis data included in this report lend a hand to businesses for planning of strategies related to investment, revenue generation, production, product launches, costing, inventory, purchasing and marketing. What's more In-vivo imaging market, report presents the data and information for actionable, most recent and real-time market insights which makes it easier to even take critical business decisions.
Download Copy of this Report to understand structure of the complete @ Market Definition:
In vivo imaging is the visualization of various life processes within an organism. With one-touch, user-defined or pre-set PC controls for repeatable and precise imaging, an in vivo imaging system aids in mechanizing in vivo imaging research. Depending on the application, in vivo imaging systems can be used on both animals and humans. In research laboratories, in vivo imaging systems are typically used to study the activity of a drug on animals such as albino mice, albino rats, and so on. These small animal imaging procedures include a full body scan as well as a targeted scan. Full body scan is a popular imaging method because it is inexpensive and can thus be used for commercialization and regular validation of new drugs.
Market Overview:
Rapid technological advancement in molecular imaging is one of the key factors expected to accelerate the growth and demand for In-vivo imaging. Furthermore, an increase in public-private initiatives and high funding to support preclinical research are expected to contribute to the global market's growth from 2023 to 2030. The rapid rise in demand for noninvasive small-animal imaging techniques and rapid advancements in healthcare services and technology are also expected to boost market growth. Furthermore, an increase in awareness of the benefits of early disease detection and an increase in the rate of clinical acceptance of multi-modality imaging systems are important factors.
Market Scope and Size:
The In-vivo imaging market is segmented on the basis of modality, reagents, techniques and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Modality
• Optical Imaging Systems
• Bioluminescence/fluorescence imaging systems
• Standalone fluorescence imaging systems
• Optical + X-ray/optical + CT
• Nuclear Imaging Systems
• Micro-PET systems
• Micro-SPECT systems
• Trimodality (SPECT/PET/CT) systems
• Micro-MRI
• Micro-Ultrasound
• Micro-CT
• Photoacoustic Imaging Systems
• Magnetic Particle Imaging Systems
Reagents
• Optical Imaging Reagents
• Bioluminescent imaging reagents
• Fluorescent imaging reagents
• Nuclear Imaging Reagents
• PET tracers and SPECT probes
• MRI Contrast Agents
• Gadolinium-based
• Iron-based
• Manganese-based
• Ultrasound Contrast Agents
• CT Contrast Agents
• Iodine-based
• Barium-based
• Gold nanoparticles
Country Level Analysis:
The countries covered in the In-vivo imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Key Players:
Some of the major players operating in the In-vivo imaging market are:
• PerkinElmer Inc. (U.S.)
• Bruker (U.S.)
• FUJIFILM Holdings America Corporation (Canada)
• Siemens (Germany)
• Miltenyi Biotec (Germany)
• CMR Naviscan (U.S.)
• SCANCO Medical AG (Switzerland)
• Aspect Imaging Ltd. (Israel)
• Mediso Ltd. (U.S.)
• LI-COR, Inc. (U.S.)
• Takara Bio Inc. (Japan)
• MILabs B.V. (Netherlands)
• MR Solutions (U.K.)
• Trifoil Imaging (U.S.)
Download Sample PDF Copy of this Report to understand structure of the complete report @ https://www.databridgemark...
TABLE OF CONTENTS:
Part 01: Executive
11 months ago
